1268521-18-1Relevant articles and documents
Pyrazinothiazole compound and application thereof, and pharmaceutical composition containing pyrazinothiazole compound
-
Paragraph 0129-0130; 0131-0134, (2020/11/09)
The invention discloses a pyrazinothiazole compound, an application of the pyrazinothiazole compound, and a pharmaceutical composition containing the pyrazinothiazole compound, and provides a pyrazinothiazole compound represented by a formula A or a pharmaceutically acceptable salt of the pyrazinothiazole compound. The pyrazinothiazole compound provided by the invention has relatively good SHP2 inhibitory activity.
HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
Paragraph 0212, (2017/03/14)
The present disclosure relates to heterocyclic compounds, and pharmaceutical compositions of the same, that are modulators/inhibitors of HDACs, such as HDAC8 and are useful in the treatment of HDAC-associated diseases.